TOMI Scales SteraMist for Ebola, Measles and Norovirus Response in Hospitals
TOMZ•TOMI Environmental Solutions reports a surge in global adoption of its SteraMist decontamination platform by healthcare providers, emergency agencies and transport operators following Ebola, measles and norovirus outbreaks. International deployments in emergency medical transport and expanded U.S. health systems programs underpin increasing biosecurity spending.
1. Accelerating Global Adoption
TOMI Environmental Solutions has seen accelerating customer adoption of its SteraMist platform across healthcare providers, emergency response agencies and transportation operators as recent Ebola, measles and norovirus outbreaks drive organizations to enhance biosecurity infrastructure.
2. Expanded Deployments
An established international partner expanded SteraMist into emergency medical transport and healthcare facilities, while U.S. health systems and federally supported preparedness programs are increasing environmental decontamination protocols using the BIT technology.
3. Market Outlook and Future Plans
The global infection prevention market is expanding, with healthcare-associated infections affecting one in 25 patients and costing tens of billions annually; TOMI anticipates sustained commercial momentum in 2026 and plans to leverage automation, robotics and autonomous delivery systems for large-scale decontamination.
